chlorpromazine has been researched along with Atrophy in 5 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Additional analysis revealed a significant positive correlation between baseline thalamic volume and dosage of typical antipsychotic medication." | 5.33 | Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. ( Goghari, VM; Honer, WG; Khorram, B; Kopala, LC; Lang, DJ; Rui, Q; Smith, GN; Vandorpe, RA, 2006) |
| "Long-term (6 months) administration of 25 mg/kg body weight/day chlorpromazine (CPZ) to rats resulted in remarkable inhibition of normal increase with age of osmiophilic lipid droplets (OLD) in the pineal gland, and atrophy of pinealocytes." | 3.66 | Effects of long-term administration of chlorpromazine on the pineal gland of rats. ( Horita, N; Ishii, T; Moroji, T, 1978) |
| " Additional analysis revealed a significant positive correlation between baseline thalamic volume and dosage of typical antipsychotic medication." | 1.33 | Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. ( Goghari, VM; Honer, WG; Khorram, B; Kopala, LC; Lang, DJ; Rui, Q; Smith, GN; Vandorpe, RA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FOLK, G | 1 |
| Khorram, B | 1 |
| Lang, DJ | 1 |
| Kopala, LC | 1 |
| Vandorpe, RA | 1 |
| Rui, Q | 1 |
| Goghari, VM | 1 |
| Smith, GN | 1 |
| Honer, WG | 1 |
| Horita, N | 1 |
| Ishii, T | 1 |
| Moroji, T | 1 |
| Feinberg, TE | 1 |
| Cianci, CD | 1 |
| Morrow, JS | 1 |
| Pehta, JC | 1 |
| Redman, CM | 1 |
| Huima, T | 1 |
| Koroshetz, WJ | 1 |
| McLaughlin, RF | 1 |
| Tyler, WS | 1 |
| Edwards, DW | 1 |
| Crenshaw, GL | 1 |
| Canada, RO | 1 |
| Fowler, MA | 1 |
| Parker, EA | 1 |
| Reifenstein, GH | 1 |
5 other studies available for chlorpromazine and Atrophy
| Article | Year |
|---|---|
[Pathogenesis & propaphenine treatment of Sudeck's atrophy].
Topics: Atrophy; Chlorpromazine; Osteoporosis; Reflex Sympathetic Dystrophy | 1959 |
Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine.
Topics: Adult; Antipsychotic Agents; Atrophy; Benzodiazepines; Chlorpromazine; Chronic Disease; Female; Foll | 2006 |
Effects of long-term administration of chlorpromazine on the pineal gland of rats.
Topics: Animals; Atrophy; Chlorpromazine; Lipids; Male; Pineal Gland; Rats; Time Factors | 1978 |
Diagnostic tests for choreoacanthocytosis.
Topics: Acanthocytes; Atrophy; Blood Cells; Brain; Chlorpromazine; Chorea; Corpus Striatum; Edetic Acid; Fem | 1991 |
Chlorpromazine-induced emphysema. Results of an initial study in the horse.
Topics: Animals; Atrophy; Bronchial Arteries; Bronchial Diseases; Chlorpromazine; Endarteritis; Horses; Inje | 1965 |